Progressive multifocal leukoencephalopathy, efalizumab, and immunosuppression: a cautionary tale for dermatologists.
Korman
Benjamin D
BD
Murdough Family Center for Psoriasis, Department of Dermatology, University Hospitals Case Medical Center, 11100 Euclid Ave, Cleveland, OH 44106, USA.
Tyler
Kenneth L
KL
Korman
Neil J
NJ
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018845:CD11 Antigens; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007577:JC Virus; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D012307:Risk Factors; D012871:Skin Diseases / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018845:CD11 Antigens; D007166:Immunosuppressive Agents; C472181:efalizumab